Phase 2; Low Dose MYOBLOC (15,000 Units)
SN-SPAS-202
Phase 3 small_molecule terminated
Quick answer
Phase 2; Low Dose MYOBLOC (15,000 Units) for Spasticity is a Phase 3 program (small_molecule) at SUPERNUS PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- SUPERNUS PHARMACEUTICALS, INC.
- Indication
- Spasticity
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated